FORA vs NBIX · rev $20.2M vs P/E 45, rev $2.36B
Forian Inc (FORA) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Forian Inc (FORA) is a health information services company listed on NASDAQ.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported FORA revenue for 2024-12-31 was $20.2M. Net income was -$3.8M. Revenue was down 5.0% from 2023-12-31 to 2024-12-31. FORA currently screens at market cap $67.8M.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
FORA currently screens at market cap $67.8M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the FORA and NBIX stock pages for the full models.
Not investment advice.